Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Accounts Payable & Accrued Expense : ¥2,238 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Jiangsu Hengrui Pharmaceuticals Co Accounts Payable & Accrued Expense?

Jiangsu Hengrui Pharmaceuticals Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥2,232 Mil) to Dec. 2023 (¥2,343 Mil) but then declined from Dec. 2023 (¥2,343 Mil) to Mar. 2024 (¥2,238 Mil).

Jiangsu Hengrui Pharmaceuticals Co's annual accounts payable & accrued expense declined from Dec. 2021 (¥3,167 Mil) to Dec. 2022 (¥2,180 Mil) but then increased from Dec. 2022 (¥2,180 Mil) to Dec. 2023 (¥2,343 Mil).

Jiangsu Hengrui Pharmaceuticals Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Jiangsu Hengrui Pharmaceuticals Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Hengrui Pharmaceuticals Co Accounts Payable & Accrued Expense Chart

Jiangsu Hengrui Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

2,250.00

3,405.34

3,166.92

2,179.82

2,343.33

Jiangsu Hengrui Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															2,316.40	2,020.29	2,231.90	2,343.33	2,237.88

Jiangsu Hengrui Pharmaceuticals Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 38, Huanghe Road, Economic, Economic and Technological Development Zone, Jiangsu Province, Lianyugang, CHN, 222047

Website

http://www.hrs.com.cn

Jiangsu Hengrui Pharmaceuticals Co Ltd is engaged in the field of cancer treatment drugs, surgical medicines, endocrine therapy drugs, cardiovascular drugs and anti-infection medications. It specializes in the research and development of new medicines in areas of antineoplastics, endocrine system, cardiovascular, and the immune system.

Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Headlines

No Headlines